National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Biodefense and Related Programs
 Biodefense
  About
  For Researchers
   Introduction
   Resources
   Funding
    FY2003 Awards
    FY2004 Awards
    FY2005 Awards
    FY2006 Awards
    FY2007 Awards
   Meetings
   Category A-C Pathogens
  Public and Media
 Radiation Countermeasures
 Chemical Countermeasures



Biodefense

Cooperative Research for the Development of Vaccines, Adjuvants, Therapeutics, Immunotherapeutics, and Diagnostics for Biodefense and SARS (U01, U19)

FY 2005 Awards

InstitutionPI NameTitle
Akubio, Ltd.Matthew CooperAcoustic detection of viruses bacteria and toxins
Arizona State UniversityCharles ArntzenDevelopment of a vaccine for Ebola virus in plant system
Brigham and Women's HospitalMark PerrellaDNA Minor Groove-binding Drugs and Food-borne Pathogens
Callisto Pharmaceuticals, Inc.Kunwar ShailubhaiPeptide & antibodies as antidotes for superantigens
CombinatoRx, Inc.Lisa JohansenCombination Therapies to Counteract Anthrax Toxin
Drexel University College of MedicineTimothy BlockImino sugars for flavivirus infections of bioterror
Duke UniversityYou HePattern Recognition Molecule Mindin As Adjuvant
Flinders University of South AustraliaNikolai PetrovskyNovel vaccine adjuvants to counter bioterrorist threats
Idaho TechnologyMark PoritzDifferentiation of Common Respiratory Viruses and SARS
Institute of Materia MedicaGang LiuDevelopment of peptide-based vaccine against SARS-CoV
Intercell AGEszter NagyA single-dose prophylactic Japanese Encephalitis vaccine
Iomai CorporationLarry EllingsworthImmunostimulatory Patch To Enhance Biodefense Vaccines
Lifepharms, Inc.Esteban MenaInhibitors of poxvirus enzymes as novel drugs
Mapp Biopharmaceuticals, Inc.Larry ZeitlinMonoclonal Antibodies in Biodefense: Ebola Viruses
Novavax, Inc.Gale SmithDevelopment of Recombinant SARS VLP Vaccines
Omrix Biopharmaceuticals Israel NurEnriched IVIG for the treatment of West Nile Virus
Perlegen Sciences, Inc.Renee StokowskiSignature SNPs to distinguish Yersinia pestis strains
Scripps Research InstituteKim JandaHuman Monoclonal Antibodies against Botulinum Toxins
SRI InternationalRae BurkeNeutralizing Botulinum Neurotoxin with Human Antibodies
St. Luke's-Roosevelt Institute for Health SciencesMalgorzata SimmHRF, an NFkB antagonist targeting multiple pathogenes
TSRL, Inc.John HilfingerOral Antiviral Prodrugs for Biodefense Initiative
University of AlbertaMavanur SureshUltrasensitive Bispecific Antibody Assay for SARS Virus
University of Nevada, RenoThomas KozelPGA antigenemia for early diagnosis of anthrax
University of Tennessee Health Science CenterMark MillerVSV as a vector for cytokine-assisted tularemia vaccines
University of WarwickJohn LordCell responses to, and proteins exploited by, toxins
Vanderbilt UniversityJohn WikswoMetabolic Discrimination of Unknown Bacterial Pathogens
Washington UniversityMichael DiamondMonoclonal Antibody Therapy for West Nile Virus

back to top